Obradovic, D.M.; Büttner, P.; Rommel, K.-P.; Blazek, S.; Loncar, G.; von Haehling, S.; von Roeder, M.; Lücke, C.; Gutberlet, M.; Thiele, H.;
et al. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy. Cells 2022, 11, 414.
https://doi.org/10.3390/cells11030414
AMA Style
Obradovic DM, Büttner P, Rommel K-P, Blazek S, Loncar G, von Haehling S, von Roeder M, Lücke C, Gutberlet M, Thiele H,
et al. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy. Cells. 2022; 11(3):414.
https://doi.org/10.3390/cells11030414
Chicago/Turabian Style
Obradovic, Danilo Momira, Petra Büttner, Karl-Philipp Rommel, Stephan Blazek, Goran Loncar, Stephan von Haehling, Maximilian von Roeder, Christian Lücke, Matthias Gutberlet, Holger Thiele,
and et al. 2022. "Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy" Cells 11, no. 3: 414.
https://doi.org/10.3390/cells11030414
APA Style
Obradovic, D. M., Büttner, P., Rommel, K. -P., Blazek, S., Loncar, G., von Haehling, S., von Roeder, M., Lücke, C., Gutberlet, M., Thiele, H., Lurz, P., & Besler, C.
(2022). Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy. Cells, 11(3), 414.
https://doi.org/10.3390/cells11030414
